| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6182659 | Gynecologic Oncology | 2015 | 8 Pages |
Abstract
When risk-adjusted for the higher prevalence of adverse prognostic factors in elderly EC patients, progression-free survival after primary therapy is not age dependent but the less favorable cause-specific survival in this cohort may reflect age-related postrecurrence treatment differences.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Mariam M. AlHilli, Jamie N. Bakkum-Gamez, Andrea Mariani, Amy L. Weaver, Michaela E. McGree, Gary L. Keeney, Aminah Jatoi, Sean C. Dowdy, Karl C. Podratz,